TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2009: $303.42M2010: $235.03M2011: $163.92M2012: $153.47M2013: $150.18M2014: $143.33M2015: $121.80M2016: $342.59M2017: $228.30M2018: $272.84M2019: $956.44M2020: $2.39B2021: $3.06B2022: $3.70B2023: $4.05B2024: $4.17B2025: $4.18B$4.18B
2009Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$4.18B+0.1%
2024$4.17B+3.0%
2023$4.05B+9.3%
2022$3.70B+21.3%
2021$3.06B+27.8%
2020$2.39B+150.0%
2019$956.44M+250.6%
2018$272.84M+19.5%
2017$228.30M-33.4%
2016$342.59M+181.3%
2015$121.80M-15.0%
2014$143.33M-4.6%
2013$150.18M-2.1%
2012$153.47M-6.4%
2011$163.92M-30.3%
2010$235.03M-22.5%
2009$303.42M—